1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Alberto Abaterusso
Alberto Abaterusso
Articles (1556) 

3 High-Performing Stocks

Clinuvel Pharmaceuticals tops the list

July 12, 2019 | About:

The following stocks have performed very well over the past several years.

Additionally, the following securities have a moderate to strong balance sheet, which increases the likelihood of continuing to produce impressive margins even though they are not trading cheaply.

Analysts recommend to maintain holdings of all three stocks.

Clinuvel Pharmaceuticals Ltd. (CLVLY) has climbed 4.6% over the past month, 91.5% so far this year, 195% over the last 52 weeks and 558.7% over the past three years through July 11. The company paid an annual dividend of 1.4 cents per share last October.

The Australian biotechnology company was trading around $24.7 per share at close on Thursday for a market capitalization of $1.21 billion.

The stock has a price-earnings ratio of 108.82, a price-sales ratio of 67.66 and a price-book ratio of 40.11, indicating, along with the Peter Lynch chart, that the stock is overpriced.

GuruFocus assigned a very high financial strength rating of 9.8 out of 10 and a profitability and growth rating of 7 out of 10.

Wall Street issued a hold recommendation rating for shares of Clinuvel Pharmaceuticals.

Repro-Med Systems Inc. (REPR) has gained 44.3% over the past month, 83.6% year to date, 150.4% over the last 52 weeks and 588.6% over the past three years through July 11. The company doesn’t pay a dividend.

Shares of the Chester, New York-based manufacturer of portable medical devices closed at $3.03 on Thursday for a market capitalization of $116.10 million.

The stock has a price-earnings ratio of 303, a price-sales ratio of 6.46 and a price-book ratio of 12.9. The Peter Lynch chart suggests Repro-Med Systems is overvalued.

Repro-Med Systems benefits, however, from a robust balance sheet as GuruFocus assigned a rating of 7.6 out of 10 for financial strength. GuruFocus also gave a high rating of 7 out of 10 for its profitability and growth.

Wall Street issued a buy recommendation rating for shares of Repro-Med Systems.

VolitionRX Ltd. (VNRX) has gained 11.3% over the past month, 86.7% year to date, 57.2% over the last 52 weeks and 2.1% over the past three years through July 11. The company doesn’t pay a dividend.

Shares of the Singapore-based diagnostics and research company closed at $3.38 on Thursday for a market capitalization of $133.43 million. It has a price-book ratio of 8.07 versus the industry median of 3.55.

GuruFocus assigned a rating of 5.8 out of 10 for the financial strength, indicating the company's balance sheet is moderately solid. In regard to profitability and growth, GuruFocus gave a low rating of 3 out of 10.

Wall Street issued a buy recommendation rating for shares of VolitionRX.

Disclosure: I have no positions in any securities mentioned.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here

About the author:

Alberto Abaterusso
If somebody asks what being a value investor means, Alberto Abaterusso would answer, “The value investor is not just the possessor of the security that represents the company, but he is the owner of that company. As an owner of the company the value investor is actively involved in the dynamics of that company and his first concern is how to have sales progressively growing. Also, the value investor is probably one of the most demanding persons in the world concerning sales.”

Abaterusso is a freelance writer based in The Netherlands. He primarily writes about gold, silver and precious metals mining stocks. His articles have also been widely linked by popular sites, including MarketWatch, Financial Times, 24hGold, Investopedia, Financial.org, CNBS, MSN Money, Zachs, Reuters and others. Alberto holds an MBA from Università degli Studi di Bari (Italy), Aldo Moro.

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by Alberto Abaterusso


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK